![](https://siapsprogram.org/wp-content/uploads/2019/11/17-133_Thumb_Page_01-100x129.png)
Project dates: September 2012 – March 2017
Project dates: September 2012 – March 2017
In September 2015, USAID’s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) helped the Uzbek Ministry of Health (MOH) successfully complete a nationwide roll-out of QuanTB, a tuberculosis (TB) quantification tool. QuanTB is a downloadable desktop tool that transforms complicated calculations into a user-friendly dashboard displaying key information for managing medicines. By serving as … Read more
In mid-June the USAID-funded SIAPS program assisted the Uzbek Ministry of Health in updating their Logistics Management and Information System (LMIS) for tuberculosis (TB) treatment medicines. Originally implemented in in 2003, the paper-based system was in need of major revisions, and in-country TB drug management specialists hadn’t been trained on the LMIS in over seven … Read more
A comprehensive indicator-based assessment of the tuberculosis (TB) in pharmaceutical management system, which was conducted with SIAPS assistance in July-August of 2014, revealed crucial needs for strengthening the anti-TB medicines supply system in Uzbekistan through improved supply planning and implementation of an early warning mechanism in order to avoid problems with stocks-outs and expiration of … Read more
Three members of the SIAPS team presented at the 2015 Global Health Mini-University, held on Monday, March 2, at the George Washington University’s Cloyd Heck Marvin Center in Washington, DC. SIAPS Technical Associate Shirin Kakayeva presented on multidrug-resistant tuberculosis (MDR-TB) in Central Asia, highlighting the high MDR-TB burden in Tajikistan (13%) and Uzbekistan (23%) in particular. Kakayeva discussed the … Read more
By Shirin Kakayeva, SIAPS Technical Associate and Dr. Archil Salakaia, SIAPS Central Asia Portfolio Manager Uzbekistan is one of 18 high-priority countries in the WHO’s European region, and is among 27 high-burden multidrug-resistant tuberculosis (MDR-TB) countries in the world. As the uninterrupted supply of anti-TB medicines is necessary for the survival of TB patients, pharmaceutical management … Read more
To ensure successful treatment and prevention of TB, countries should have strong pharmaceutical management systems to ensure uninterrupted supply of quality anti-TB medicines. Acknowledging shortcomings of the existing TB pharmaceutical management system (TB PM), Uzbekistan’s Ministry of Health (MOH) requested that SIAPS provide assistance and conduct a countrywide TB PM assessment. SIAPS, in collaboration with … Read more